Drugmakers Face Massive U.S. Price-Fixing Lawsuit Over Skincare Generics
A U.S. federal judge has ruled that 36 drugmakers and top executives must face nearly all claims in a major antitrust lawsuit alleging they conspired to fix prices of 80 generic drugs. The case is led by Connecticut and joined by 45 states, the District of Columbia, and four U.S. territories. The companies, which include…